Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
MCK

MCK - McKesson Corp Stock Price, Fair Value and News

$826.62-7.56 (-0.91%)
Market Closed

57/100

MCK

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

57/100

MCK

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$839.1

Target 3M

$825.15

Target 6M

$829.25

MCK Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

MCK Price Action

Last 7 days

0.4%

Last 30 days

-0.5%

Last 90 days

0.1%

Trailing 12 Months

37.1%

MCK RSI Chart

MCK Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

MCK Valuation

Market Cap

102.0B

Price/Earnings (Trailing)

25.3

Price/Sales (Trailing)

0.26

EV/EBITDA

22.15

Price/Free Cashflow

16.05

MCK Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$839.1

Target 3M

$825.15

Target 6M

$829.25

MCK Fundamentals

MCK Revenue

Revenue (TTM)

387.1B

Rev. Growth (Yr)

10.14%

Rev. Growth (Qtr)

5.44%

MCK Earnings

Earnings (TTM)

4.0B

Earnings Growth (Yr)

360.58%

Earnings Growth (Qtr)

41.58%

MCK Profitability

Operating Margin

47.67%

EBT Margin

1.13%

Return on Equity

-297.64%

Return on Assets

4.79%

Free Cashflow Yield

6.23%

MCK Investor Care

Dividend Yield

0.36%

Dividend/Share (TTM)

2.95

Buy Backs (1Y)

4.54%

Diluted EPS (TTM)

32.03

MCK Alerts

  • 1 major insider sales recently.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025359.1B377.6B387.1B0
2024309.0B313.8B330.2B344.6B
2023276.7B284.0B291.1B301.5B
2022264.0B268.4B272.0B273.9B
2021238.2B245.2B251.0B257.0B
2020231.1B231.0B234.2B237.6B
2019214.3B217.4B222.0B224.9B
2018208.4B209.9B210.9B213.5B
2017198.5B199.9B202.0B205.4B
2016190.9B193.1B194.3B196.5B
2015179.0B183.1B187.7B189.1B
2014137.4B148.6B159.8B172.0B
2013122.1B123.6B126.8B130.1B
2012122.7B123.5B123.0B123.3B
2011112.1B114.6B117.3B119.9B
2010000109.9B
Get all data in R, Python etc through our Historical Stock Data APIs

About McKesson Corp

MCK
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment offers distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
 CEO
 WEBSITEmckesson.com
 SECTORHealthcare
 INDUSTRYMedical Distribution
 EMPLOYEES45000

McKesson Corp Frequently Asked Questions

MCK is the stock ticker symbol of McKesson Corp. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of McKesson Corp is 102.03 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check MCK's fair value in chart for subscribers.

The fair value guage provides a quick view whether MCK is over valued or under valued. Whether McKesson Corp is cheap or expensive depends on the assumptions which impact McKesson Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MCK.

As of Wed Jan 28 2026, MCK's PE ratio (Price to Earnings) is 25.3 and Price to Sales (PS) ratio is 0.26. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MCK PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, McKesson Corp has provided 0.178 (multiply by 100 for percentage) rate of return.